Researchers tracking nearly 1,000 individuals with post-COVID-19 syndrome observed minimal changes in their symptoms during ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

The AHA's 2025 report highlights alarming trends in cardiovascular disease, obesity, and lifestyle factors, emphasizing the ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Dr Amir Khan has warned over a condition that affects one in five Brits - and can be caused by a range of factors with very ...

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule ...

These evaluations measure how efficiently the body converts nutrients into energy, assessing mitochondrial function, insulin ...

Medical community is united in its concern about the adverse effects of long working hours, especially those in desk jobs ...

Researchers have recently uncovered new insights into how the brain’s reward system functions in individuals with ...

Most people experience sugar cravings, but it's important to keep your sugar intake low to reduce your risk of health ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...